MADISON,
Wis., Sept. 3, 2024 /PRNewswire/ -- Accuray
Incorporated (NASDAQ: ARAY) announced today that President and
Chief Executive Officer Suzanne
Winter will be taking a temporary medical leave of absence
to receive care for a treatable form of cancer, effective
immediately. Accuray Senior Vice President and Chief Commercial
Officer Sandeep Chalke will serve as
the interim CEO during Ms. Winter's absence. To ensure that Mr.
Chalke and the organization have the necessary support, the company
has formed an Executive Committee of the Board of Directors,
consisting of Joseph Whitters,
Chairman of the Accuray Board, and Anne Le
Grand, Chair of the Science and Technology Committee, that
will advise Mr. Chalke in his interim capacity.
"As the head of an incredible company whose mission is to
conquer cancer, I remain grateful for how far the industry has come
in overcoming this disease, including the development of advanced
diagnostic tools that can detect it in early stages. I go into my
treatment program extremely knowledgeable and able to advocate for
the care I need," said Suzanne
Winter, President and CEO of Accuray.
"Suzanne will be in the thoughts of the Board and the global
Accuray organization while she takes time to prioritize her
health," said Joseph Whitters,
Chairman of the Board at Accuray. "In the interim, the Board and I
are extremely confident in Sandeep and the strong leadership team
that Suzanne has built. I am certain that they are well positioned
to continue delivering on the organization's vision and strategic
priorities while concurrently running day-to-day operations."
Mr. Chalke joined Accuray in May
2022 bringing more than 30 years of medical device expertise
in commercialization, business development and operations. In his
role at Accuray, he has responsibility for the global commercial
function, including the organization's sales, service and
operations teams.
About Accuray
Accuray Incorporated is committed to expanding the powerful
potential of radiation therapy to improve as many lives as
possible. We invent unique, market-changing solutions that are
designed to deliver radiation treatments for even the most complex
cases—while making commonly treatable cases even easier—to meet the
full spectrum of patient needs. We are dedicated to continuous
innovation in radiation therapy for oncology, neuro-radiosurgery,
and beyond, as we partner with clinicians and administrators,
empowering them to help patients get back to their lives, faster.
Accuray is headquartered in Madison,
Wisconsin, with facilities worldwide. To learn more, visit
www.accuray.com or follow us on Facebook, LinkedIn, X, and
YouTube.
Investor Contact
Aman Patel, CFA
Investor Relations, ICR-Westwicke
+1 (443) 450-4191
aman.patel@westwicke.com
Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/accuray-president-and-chief-executive-officer-suzanne-winter-to-take-temporary-medical-leave-of-absence-302236363.html
SOURCE Accuray Incorporated
